Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsSecurities - TradableShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Short-term Investments: 2024-2025

Historic Short-term Investments for Praxis Precision Medicines (PRAX) over the last 2 years, with Sep 2025 value amounting to $117.6 million.

  • Praxis Precision Medicines' Short-term Investments fell 37.56% to $117.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $117.6 million, marking a year-over-year decrease of 37.56%. This contributed to the annual value of $177.2 million for FY2024, which is N/A change from last year.
  • According to the latest figures from Q3 2025, Praxis Precision Medicines' Short-term Investments is $117.6 million, which was down 18.23% from $143.9 million recorded in Q2 2025.
  • Praxis Precision Medicines' Short-term Investments' 5-year high stood at $206.7 million during Q2 2024, with a 5-year trough of $55.4 million in Q1 2024.
  • Over the past 2 years, Praxis Precision Medicines' median Short-term Investments value was $162.4 million (recorded in 2025), while the average stood at $150.2 million.
  • Over the last 5 years, Praxis Precision Medicines' Short-term Investments had its largest YoY gain of 192.99% in 2025, and its largest YoY loss of 37.56% in 2025.
  • Over the past 2 years, Praxis Precision Medicines' Short-term Investments (Quarterly) stood at $177.2 million in 2024, then tumbled by 37.56% to $117.6 million in 2025.
  • Its Short-term Investments stands at $117.6 million for Q3 2025, versus $143.9 million for Q2 2025 and $162.4 million for Q1 2025.